Validation of a potency assay for CD34 + cell based therapy
Abstract ProtheraCytes (expanded autologous CD34 + cells) promote regeneration by revascularising damaged myocardial tissue via angiogenesis through the secretion of vascular endothelium growth factor (VEGF). We developed a potency assay based on the quantification of the secreted VEGF during the ex...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-14828-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|